Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma
City of Hope Medical Center
City of Hope Medical Center
City of Hope Medical Center
University of Chicago
M.D. Anderson Cancer Center
University of Washington
Alliance for Clinical Trials in Oncology
M.D. Anderson Cancer Center
Dana-Farber Cancer Institute
M.D. Anderson Cancer Center
Hackensack Meridian Health
M.D. Anderson Cancer Center
Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea
Ruijin Hospital
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
M.D. Anderson Cancer Center
Case Comprehensive Cancer Center
Ohio State University Comprehensive Cancer Center
Ruijin Hospital
Universität des Saarlandes
PrECOG, LLC.
University of Miami
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Weill Medical College of Cornell University
Sun Yat-sen University
Memorial Sloan Kettering Cancer Center
Washington University School of Medicine
City of Hope Medical Center
M.D. Anderson Cancer Center
University College, London
Dana-Farber Cancer Institute
University College, London
Sun Yat-sen University
Academic and Community Cancer Research United
University of Giessen
Weill Medical College of Cornell University
Ruijin Hospital
Medical University of Vienna
City of Hope Medical Center
Academic and Community Cancer Research United
Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea
University of Nebraska
Ruijin Hospital
Washington University School of Medicine
University of Nebraska
University of Nebraska
University of Nebraska
City of Hope Medical Center
Emory University
Abramson Cancer Center at Penn Medicine